Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Gamida Cell Ltd (NQ: GMDA )

1.620 +0.070 (+4.52%)
Streaming Delayed Price Updated: 4:00 PM EST, Jan 27, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 478,358
Open 1.550
Bid (Size) 1.550 (7)
Ask (Size) 1.670 (7)
Prev. Close 1.550
Today's Range 1.540 - 1.640
52wk Range 1.100 - 4.720
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Gamida Cell Announces Closing of $25 Million Financing With Highbridge
From Gamida Cell Ltd.
Via Business Wire
Gamida Cell to Present Corporate Highlights at Multiple Upcoming Investor Conferences
From Gamida Cell Ltd.
Via Business Wire

Performance

YTD
+14.89%
+14.89%
1 Month
+25.58%
+25.58%
3 Month
-9.50%
-9.50%
6 Month
+0.62%
+0.62%
1 Year
-51.35%
-51.35%

More News

Read More
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
Via InvestorPlace
Why American Eagle Outfitters Shares Climbed Over 18%; Here Are 78 Biggest Movers From Yesterday
Via Benzinga
Why Dollar Tree Shares Are Trading Lower By 10%? Here Are 53 Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
Why ObsEva Shares Are Trading Higher By Over 70%; Here Are 21 Stocks Moving Premarket
Via Benzinga
Gamida Cell Provides Regulatory Update on Omidubicel
From Gamida Cell Ltd.
Via Business Wire
Pinterest To $23? Plus This Analyst Slashes PT On Neoleukin Therapeutics By More Than 90%
Via Benzinga
Intellia Therapeutics To Rally Around 143%? Plus Stifel Cuts PT On This Stock By 94%
Via Benzinga
Gamida Cell Reports Third Quarter 2022 Financial Results and Provides Company Update
From Gamida Cell Ltd.
Via Business Wire
Gamida Cell to Present Corporate Highlights at the Jefferies London Healthcare Conference
From Gamida Cell Ltd.
Via Business Wire
GDA-501, NAM enabled NK Cell Therapy, Demonstrates Promising Antitumor Activity Against HER2+ Cancers
From Gamida Cell Ltd.
Via Business Wire
Gamida Cell Announces the Date of Its Third Quarter 2022 Financial Results and Webcast
From Gamida Cell Ltd.
Via Business Wire
Gamida Cell Announces Omidubicel Data To Be Presented as an Oral Presentation at 64th ASH Annual Meeting
From Gamida Cell Ltd.
Via Business Wire
Gamida Cell to Present Corporate Highlights at 2022 Cell & Gene Meeting on the Mesa
From Gamida Cell Ltd.
Via Business Wire
Flotek Industries, Clear Channel Outdoor And 2 Other Penny Stocks Insiders Are Aggressively Buying
Via Benzinga
Long-Term Data from Omidubicel Phase 3 Trial Demonstrates Overall Survival and Sustainable Durable Outcomes for Patients with Blood Cancers at the Society of Hematologic Oncology Meeting
From Gamida Cell Ltd.
Via Business Wire
Why NLS Pharmaceutics Shares Tumbled Over 66%; Here Are 68 Biggest Movers From Yesterday
Via Benzinga
Why Prothena Corporation Shares Are Trading Higher By 76%, Here Are 53 Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
Via InvestorPlace
Why MindMed Is Trading Lower By Around 35%; Here Are 31 Stocks Moving Premarket
Via Benzinga
Gamida Cell Announces Pricing of Approximately $20 Million Public Offering of Ordinary Shares
From Gamida Cell
Via Business Wire
Gamida Cell Announces Entry into Commitment Letter with Highbridge for $25 Million Financing
From Gamida Cell Ltd.
Via Business Wire
Gamida Cell Announces Launch of Public Offering of Ordinary Shares
From Gamida Cell Ltd.
Via Business Wire
Gamida Cell Appoints Abigail L. Jenkins as President and Chief Executive Officer, Bringing Broad Leadership Experience in Commercializing Innovative Therapies
From Gamida Cell Ltd.
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.